Bladder cancer : diagnosis and clinical management

Content: List of contributors vii    Preface xii    Acknowledgments xiii    Part I: Diagnosis and treatment of non?]muscle?]invasive bladder cancer    1 Pathology 3 Hikmat Al?]Ahmadie and Donna E. Hansel    2 Risk stratification of high?]grade Ta CIS and T1 urothelial carcinoma of the bladder 18 Tobias Klatte, Fred Witjes, Gary Steinberg, and Shahrokh F. Shariat    3 Utility of urine biomarkers 26 Derya Tilki and Alexandre R. Zlotta    4 Novel endoscopic techniques for the detection of bladder cancer 39 Ayman Soubra, Joseph C. Liao, and Badrinath Konety    5 Transurethral resection of bladder tumors 51 Jen?]Jane Liu and Mark P. Schoenberg    6 Intravesical chemotherapy 64 Levent N. Turkeri, M.Guillaume Wientjes, and Jessie L.S. Au    7 Intravesical immunotherapy 76 Nilay M. Gandhi, Laura A. Bertrand, Donald L. Lamm, and Michael A. O   Donnell    8 HGT1 bladder cancer: Diagnosis and treatment 89 J.M. Gaya, J. Palou, and Edward M. Messing    9 What to do when bacillus Calmette?]Guerin fails 98 Massimiliano Spaliviero, Guido Dalbagni, and Matthew Nielsen    Part II: T2   4    10 Selection and perioperative management of patients undergoing radical cystectomy and urinary reconstruction 111 Robert S. Svatek and Alon Z. Weizer    11 Radical cystectomy: Techniques and outcomes 127 Siamak Daneshmand and Seth P. Lerner    12 Cystectomy in the female patient 144 Ryan Werntz, Georgios Gakis, Theresa Koppie, and Arnulf Stenzl    13 Laparoscopic/robotic radical cystectomy and urinary diversion: Outcomes 156 Kristina Wittig, Kevin Chan, Mark Kawachi, and Timothy G. Wilson    14 Robotic assisted radical cystectomy and urinary diversion: Clinical trials 167 George J.S. Kallingal, Angela B. Smith, Raj S. Pruthi, and Dipen J. Parekh    15 Role of extended lymphadenectomy 176 Eugene K. Cha, George N. Thalmann, and Bernard H. Bochner    16 Management of the urethra in the cystectomy patient 184 Kamal S. Pohar and Norm D. Smith    17 The role of radical cystectomy in patients with unresectable or regionally metastatic urothelial carcinoma of the bladder 190 Scott Delacroix Jr, Nathan Lawrentschuk, and Ashish M. Kamat    Part III: Primary bladder?]sparing therapy    18 Radical transurethral resection 201 Eduardo Solsona and Harry W. Herr    19 Partial cystectomy 212 Ahmed Haddad, Yair Lotan, and Arthur I. Sagalowsky    20 Integrating chemotherapy and radiotherapy for bladder cancer 221 Lior Z. Braunstein, William U. Shipley, Nicholas D. James, Andrea B. Apolo, and Jason A. Efstathiou    Part IV: Urinary tract reconstruction    21 Orthotopic neobladder 235 Eila C. Skinner    22 Continent cutaneous diversion 244 Andreas Neisius and Joachim W. Thuroff    23 Non?]continent urinary diversion 258 Michael Rink, Fredrik Liedberg, and Margit Fisch    Part V: Treatment of regionally advanced and metastatic bladder cancer    24 Molecular determinants of chemotherapy response 273 Matthew I. Milowsky, Peter H. O   Donnell, Thomas W. Flaig, and Dan Theodorescu    25 Neoadjuvant chemotherapy in the treatment of muscle?]invasive bladder cancer 284 David I. Quinn and Cora N. Sternberg    26 Adjuvant chemotherapy for invasive bladder cancer 295 Andre P. Fay, Jeffrey J. Leow, and Joaquim Bellmunt    27 Treatment of metastatic bladder cancer 304 Gopa Iyer, Fabio Calabro, and Dean F. Bajorin    28 Treatment of poor risk patients 320 Maria De Santis and Matthew D. Galsky    Part VI: Genomics and the current status of urothelial cancer    29 Molecular events in muscle?]invasive bladder cancer development 329 Jonathan Rosenberg, William Y. Kim, Jaegil Kim, and David J. Kwiatkowski    30 Cancer stem cells and intrinsic subtypes in bladder cancer 342 Keith Syson Chan and David J. McConkey    31 Multi?]targeted agents in the treatment of urothelial carcinoma 353 Noah M. Hahn, Colin P.N. Dinney, and Guru Sonpavde    Part VII: Optimizing healthcare delivery    32 Patient navigation and cancer navigator programs 365 Scott M. Gilbert and Michael Porter    33 Impact of health services on compliance and outcomes 375 Heather Honore Goltz, Marc A. Kowalkowski, G. John Chen, and David M. Latini    34 Quality of life and survivorship 384 Nihal E. Mohamed and Cheryl T. Lee    35 Bladder cancer: Healthcare delivery and third party payers 395 Seth A. Strope and John L. Gore    36 Bladder cancer patient advocacy: Creating partnerships to advance patient care research and clinical trials 402 Diane Zipursky Quale and Rick Bangs    Index 409